Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edesa Biotech, Inc. - Common Shares (NQ:EDSA)

1.740 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edesa Biotech, Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Edesa Biotech Posts Narrower Loss in Q3
Via The Motley Fool
Wondering what's happening in today's pre-market session?
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
Nasdaq Surges 150 Points; Cisco Earnings Top Views
 
Via Benzinga
US Stocks Edge Higher; Producer Prices Increase In January
 
Via Benzinga
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Barclays Global Healthcare Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Dermatology Meetings
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Edesa Biotech Reports Fiscal Year 2023 Results
Via ACCESSWIRE
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! 
Via InvestorPlace
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. 
Via Benzinga
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
Via ACCESSWIRE
Edesa Biotech to Present at Dermatology Drug Development Summit
Via ACCESSWIRE
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.